Impact Factor ISSN: 1837-9664
Global reach, higher impact
Review Development of nasopharyngeal carcinoma target delineation: from two-dimensional radiotherapy to adaptive precision radiotherapy Full text PDF
Research Paper Dehydroleucodine Induces ROS-Mediated Mitochondrial Apoptosis and G2/M Cell Cycle Arrest in Oral Squamous Cell Carcinoma Full text PDF
Review The Emerging Role of CACNA1E in Cancer: Molecular Mechanisms and Therapeutic Implications Full text PDF
Research Paper Development and Validation of an m6A-Derived Prognostic Signature in Lung Adenocarcinoma Full text PDF
Research Paper Epidemiological Trends and Shared Molecular Signatures of Pancreatic Ductal Adenocarcinoma and Diabetes: An Integrative Analysis Based on Global Burden of Disease and Gene Expression Omnibus Datasets Full text PDF
Research Paper CellVizio® System for Mesothorax Lymphadenopathy Rapid on Site, 18G needle: Pros and Cons Full text PDF
Indexed in PubMed and SCI expanded; full texts in Europe PMC. ...
Background: Pancreatic ductal adenocarcinoma (PDAC) is one of the most lethal malignancies worldwide, and diabetes mellitus has been recognized as both a risk factor for and a potential consequence of PDAC. However, the epidemiological trends and shared molecular mechanisms underlying this association are not completely understood. Methods: We conducted an integrative analysis combining population-level epidemiological data and transcriptomic datasets. ...
Development and Validation of an m6A-Derived Prognostic Signature in Lung Adenocarcinoma
Background: Lung adenocarcinoma (LUAD) exhibits extensive molecular heterogeneity and poor prognosis, necessitating novel epigenetic biomarkers. N6-methyladenosine (m6A) modification, a pivotal epigenetic regulator of RNA, is frequently dysregulated in LUAD, yet its systematic roles in clinical prognosis and the tumor microenvironment (TME) remain poorly elucidated. Methods: Transcriptomic profiles and clinical data from large-scale cohorts were integrated ...